|Articles|November 17, 2015
Parexel Adds Clinical Development Optimization
Advertisement
Parexel has enhanced its end-to-end clinical development services through its new Clinical Development Optimization process, which uses advanced technology to help expedite drug development through all four critical stages of clinical development – design, start-up, trial execution, and submission.
- Design: Protocol design optimization uses simulations to allow sponsors to identify and quantify the impact of trade-off decisions on program performance, timelines and cost.
- Start-up: Site start-up, Clinical Trial Management System, and electronic Trial Master File integrated applications provide efficient distribution, collaborative compilation and e-signing of site-level regulatory documents and contracts. Clinical Trial Supplies & Logistics handles supply chain challenges and optimizes supply levels.
- Execute: Intelligent technology from the PAREXEL Informatics product line helps predict and capture core operational and scientific data.
- Submit: Data aggregation aligned with commercial decision-making strategy can help ensure the right technology and operational support for an initial regulatory application, identification of future opportunities, and product lifecycle management.
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Using AI Trial-Matching Tools to Accelerate Patient Access
September 8th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
2
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
3
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
4
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
5